NCT02575365View on ClinicalTrials.gov

Effect of Fingolimod on Neurodegeneration

PHASE4TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 16, 2016

Primary Completion Date

January 27, 2017

Study Completion Date

January 27, 2017

Conditions
CognitionBrain Volume Loss
Interventions
DRUG

0,5 mg Fingolimod

0.5 mg p.o fingolimod daily

Trial Locations (3)

16059

Novartis Investigative Site, Bursa

41380

Novartis Investigative Site, Kocaeli

43000

Novartis Investigative Site, Kütahya

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY